Dimensional Fund Advisors
STRO icon

Dimensional Fund Advisors’s Sutro Biopharma STRO Stock Holding History

Dimensional Fund Advisors’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,752
Closed -$172K – 3319
2025
Q3 		$172K Sell
19,752
-43,095
-69% -$367K ﹤0.01% 3139
2025
Q2 		$449K Sell
62,847
-18,901
-23% -$155K ﹤0.01% 3012
2025
Q1 		$533K Sell
81,748
-31,898
-28% -$502K ﹤0.01% 2995
2024
Q4 		$2.09M Buy
113,646
+15,614
+16% +$477K ﹤0.01% 2776
2024
Q3 		$3.39M Sell
98,032
-10,496
-10% -$411K ﹤0.01% 2644
2024
Q2 		$3.18M Sell
108,528
-22,360
-17% -$884K ﹤0.01% 2637
2024
Q1 		$7.4M Buy
130,888
+16,812
+15% +$743K ﹤0.01% 2439
2023
Q4 		$4.89M Buy
114,076
+1,094
+1% +$34.7K ﹤0.01% 2567
2023
Q3 		$3.92M Sell
112,982
-8,197
-7% -$357K ﹤0.01% 2607
2023
Q2 		$5.63M Buy
121,179
+3,859
+3% +$192K ﹤0.01% 2478
2023
Q1 		$5.42M Buy
117,320
+50,566
+76% +$3.21M ﹤0.01% 2461
2022
Q4 		$5.39K Buy
66,754
+21,096
+46% +$1.47M ﹤0.01% 2423
2022
Q3 		$2.53M Buy
45,658
+9,293
+26% +$550K ﹤0.01% 2641
2022
Q2 		$1.9M Sell
36,365
-8,331
-19% -$465K ﹤0.01% 2756
2022
Q1 		$3.67M Buy
44,696
+8,619
+24% +$820K ﹤0.01% 2625
2021
Q4 		$5.37M Buy
36,077
+10,969
+44% +$1.97M ﹤0.01% 2540
2021
Q3 		$4.74M Sell
25,108
-8,711
-26% -$1.66M ﹤0.01% 2605
2021
Q2 		$6.29M Sell
33,819
-2,399
-7% -$470K ﹤0.01% 2533
2021
Q1 		$8.23M Buy
36,218
+26,363
+268% +$6.26M ﹤0.01% 2407
2020
Q4 		$2.14M Buy
+9,855
New +$1.63M ﹤0.01% 2790

Other funds holding STRO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Dimensional Fund Advisors's STRO Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of Sutro Biopharma (STRO) in Q4 2025, closing a stake of 19,752 shares — an estimated $172K sold.

Dimensional Fund Advisors first reported a position in STRO in Q4 2020 and held it in 20 quarters. The position peaked at $8.23M in Q1 2021. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining Sutro Biopharma position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 19,752 Sutro Biopharma shares in Q4 2025, an estimated $172K.
  • Dimensional Fund Advisors first reported a position in Sutro Biopharma in Q4 2020 and held it in 20 quarters.
  • Dimensional Fund Advisors's Sutro Biopharma position peaked at $8.23M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.